3/12/2009 | CV | Cytyc calls 2.25% convertibles
|
10/22/2007 | CV | Cytyc begins change-of-control tender offer for 2.25% convertibles
|
10/22/2007 | SS | Merger of Hologic and Cytyc is complete
|
10/18/2007 | SS | Hologic, Cytyc shareholders say yes to merger deal
|
10/12/2007 | SS | Farallon Capital announces 49.3% ownership of Cytyc
|
10/11/2007 | SS | Market Commentary: Schering-Plough dips but gets European go-ahead to buy Organon; Sallie Mae up as other investors circle
|
9/12/2007 | SS | Hologic, Cytyc set meeting date for merger votes
|
7/19/2007 | CV | Cytyc announces convertability of 21/4% senior notes due 2024
|
7/3/2007 | SS | Hologic, Cytyc announce expiration of waiting period for merger
|
5/21/2007 | CV | Market Commentary: Cytyc surges on buyout; International Game falls on report, buyout uncertainty; LifePoint launches deal
|
5/21/2007 | SS | Hologic, Cytyc merger to create $10 billion global women's health care company
|
5/21/2007 | SS | Market Commentary: Alltel may see better bid; Cytyc climbs, Hologic hit; Pioneer up; Atlas Energy advances; WCI off
|
4/3/2007 | SS | Cytyc-acquired Adeza Biomedical to operate under new name
|
4/2/2007 | SS | Cytyc completes $24-per-share cash tender offer for Adeza Biomedical
|
3/19/2007 | SS | Cytyc accepts 87.4% of Adeza shares in tender offer, extends subsequent offering period
|
3/16/2007 | SS | Cytyc completes acquisition of Adiana
|
2/26/2007 | BK | Cytyc to use existing credit facility for Adiana purchase
|
2/12/2007 | BK | Cytyc to use existing facility for Adeza purchase
|
2/12/2007 | SS | Cytyc to acquire Adeza Biomedical in $24-per-share tender offer
|
10/13/2006 | BKBT | Cytyc amends loan, increasing revolver size to $345 million
|
9/18/2006 | BT | Ventana will not raise offer for Vision Systems to match Cytyc bid, prepares to file patent case
|
9/14/2006 | BK | Cytyc may draw on existing facility for proposed Vision tender offer
|
9/13/2006 | BT | Cytyc offers A$497 million for Vision Systems
|
6/30/2006 | BKBT | Cytyc gets $150 million revolver
|
2/17/2006 | BT | Market Commentary: Cytyc shares, convertibles gain big; Alkermes slips on FDA news; NPS Pharma off amid uncertainty
|
11/21/2005 | BT | Cytyc announces $200 million four-year stock repurchase program
|
10/28/2004 | CVHY | Cytyc files $400 million shelf
|
3/18/2004 | CV | Market Commentary: CommScope bid plus 0.875 point over par in gray market; Greater Bay up 0.75 point; Saks about par
|
3/17/2004 | CV | New Issue: Cytyc $220 million convertible yields 2.25%, up 50%
|
3/17/2004 | CV | Market Commentary: Cytyc goes to 104.375; XL prices at tight end of revised talk; Saks, Greater Bay, CommScope appear
|
3/16/2004 | CV | Market Commentary: Cytyc bid 3 points over par in gray market; XL brings $750 million mandatory as expected
|
3/15/2004 | CV | Cytyc $220 million convertible talked at 2.25-2.75%, up 45-50%
|
3/15/2004 | CV | Market Commentary: Providian, CapitalSource, Cytyc deals emerge; InVision Tech up 6.5 points on acquisition by GE
|